Incidence of Residual Neuromuscular Blockade in Fraility in OncoGynae Surgery

Sponsor
Mahidol University
Study ID
NCT06216002
Status
Recruiting
Apply to this trial

Conditions

  • Frailty
  • General Anesthetic Drug Adverse Reaction
  • Gynecologic Cancer
  • Neuromuscular Blockade
  • Surgical Complication

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Train of four nerve stimulator — DIAGNOSTIC_TEST
    Patient receive nerve stimulation by TOF-scan equipment at recovery room after surgery.

Study Details

Frailty among patients undergoing surgery is strongly associated with an elevated risk of adverse perioperative outcomes, heightened incidence of postoperative complications, increased mortality rates, and prolonged hospital length of stay. Our focus centers on investigating the frailty index in the context of complications experienced by patients undergoing oncologic gynecology surgery. The principal objective of this research is to elucidate the extent to which residual neuromuscular blocking agents are linked to frailty.

Key Dates

First listed
Jan 22, 2024
Start date
Jan 2, 2024
Status verified
May 2025
Primary completion
Dec 31, 2025
Completion
Dec 31, 2025

Study Design

Enrollment
622 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: TOF nerve stimulation
    Patient receive TOF nerve stimulation in recovery room after surgery

Primary Outcome Measure

Incidence of residual neuromuscular blockade [ Time Frame: 0-30 minute after surgery ]

Central Contacts

Related Studies